D
J. Weber et al.
Letter
Synlett
(16) (2-Benzyloxyphenyl) Acetic Acid, Cyclohexylmethyl Ester 8
Starting from cyclohexyl methanol (114 mg, 0.1 mmol) and fol-
lowing general procedure A BnPAc ester 8 was obtained as a
white solid (315 mg, 93%). For analytical data see Supporting
Information.
(23) General Procedure C: Glycosylation with Donor 11
To a solution of the acceptor (680 μmol, 2.5 equiv) and glucosyl
donor 11 (200 mg, 272 μmol, 1 equiv) in dry CH2Cl2 (5 mL)
molecular sieves (3 Å, 100 mg/mL) were added, and the reaction
mixture was stirred for 2 h at r.t. After cooling to –10 °C, N-iodo-
succinimide (133 mg, 544 μmol, 2 equiv), followed by trifluoro-
methanesulfonic acid (5 μL, 54 μmol, 0.2 equiv) were added,
and stirring was continued for 16 h. The reaction was quenched
by addition of saturated aqueous NaHCO3 and Na2SO3 solutions
(1:1, 1 mL), then the reaction solution was diluted with CH2Cl2
(4 mL) and filtered through Celite®. The filtrate was washed
with water (5 mL) and brine (3 mL), dried over Na2SO4, filtered,
and concentrated under reduced pressure. The residue was
purified by column chromatography (hexanes/EtOAc gradient
elution) to obtain the desired product.
(17) (2-Benzyloxyphenyl) Acetic Acid, 3,4-di-O-Benzyl Glucuronal
Ester 9
Starting from 3,4-di-O-benzyl glucuronal (200 mg, 0.61 mmol)
and following general procedure A BnPAc ester 9 was obtained
(276 mg, 82%). For analytical data see Supporting Information.
(18) (2-Benzyloxyphenyl) Acetic Acid, 1,2,5,6-Diisopropylidene
Glucosyl Ester 10
Starting from diacetone-D-glucose (50 mg, 0.19 mmol) and fol-
lowing general procedure A BnPAc ester 10 was obtained
(80 mg, 86%). For analytical data see Supporting Information.
(19) Ethyl 3,4,6-Tri-O-benzyl-2-O-[(2-benzyloxyphenyl)acetyl]-1-
thio-β,D-glucoside (11)
(24) 2-Phenylethyl
3,4,6-Tri-O-benzyl-2-O-[(2-benzyloxy-phe-
nyl)acetyl]-β,D-glucoside (12)
Starting from ethyl 3,4,6-tri-O-benzyl-1-thio-β,D-glucoside
(4.4 g, 9 mmol) and following general procedure A glucosyl
donor 11 was obtained as a white solid (5.2 g, 88%). For analyti-
cal data see Supporting Information.
General procedure C; starting from phenylethanol (83 mg,
0.68 mmol) and glucosyl donor 11 (200 mg, 0.27 mmol) 12 was
obtained as a white solid (90 mg, 88%). For analytical data see
Supporting Information.
(20) General Procedure B1: Deprotection of BnPAc via Catalytic
Hydrogenation
(25) Methyl 2,3,4,9,10,12-Hexa-O-benzyl-8-O-[(2-benzyloxy-phe-
nyl)acetyl]-α,D-gentiobioside (15)
To a solution of the respective BnPAc-protected compound
(0.07 mmol, 1 equiv) in dry ethanol (1.5 mL) one small tip of a
spatula of Pd/C was added under an argon atmosphere. The
argon balloon was changed for a H2 balloon, and the reaction
mixture was stirred for 3–6 h at r.t. The reaction mixture was
filtered through a syringe filter, proton sponge (1 equiv) was
added to the filtrate, and the reaction solution was heated up to
80 °C until completion of the reaction (4–8 h). The reaction
mixture was concentrated, and the residue was purified either
by flash chromatography (gradient elution hexanes/EtOAc) or
by preparative HPLC (H2O/MeCN) to yield the corresponding
product.
General procedure C; starting from glucosyl donor 11 (60 mg,
0.08 mmol) and acceptor 14 (93 mg, 0.2 mmol) 15 (83 mg, 91%)
was obtained. For analytical data see Supporting Information.
(26) 2-Phenylethyl-β,D-glucoside (13)
Starting from compound 12 (36 mg, 0.05 mmol) and following
general procedure B1 13 was obtained as a white solid (12 mg,
84%). Analytical data matched those reported in the literature.30
(27) Methyl 2,3,4,9,10,12-Hexa-O-benzyl-α,D-gentiobioside (16)
Starting from compound 15 (50 mg, 0.04 mmol) and following
general procedure B2 16 was obtained as a white solid (37 mg,
95%). For analytical data see Supporting Information.
(28) trans-N-(tert-Butoxycarbonyl)-4-acetoxy-L-proline,
3,4,6-
(21) General Procedure B2: Deprotection of BnPAc via basic
hydrolysis
Tri-O-benzyl-2-O-[(2-benzyloxyphenyl) Acetyl]-β,D-glucosyl
Ester (18)
To a solution of the respective BnPAc-protected compound in
dry methanol K2CO3 (0.5 equiv) was added. The reaction
mixture was stirred for 16 h at room temperature. In some
cases, further addition of 0.5 equiv NaOMe was necessary for
completion of the reaction. The reaction mixture was filtered,
concentrated and the residue was purified by flash chromatog-
raphy (gradient elution hexanes/EtOAc) or by preparative-HPLC
(H2O/MeCN) to obtain the desired product.
General procedure C; starting from glucosyl donor 11 (100 mg,
0.14 mmol) and acceptor 17 (57 mg, 0.21 mmol) 18 (80 mg,
62%) was obtained. For analytical data see Supporting Informa-
tion..
(29) trans-N-(tert-Butoxycarbonyl)-4-acetoxy-L-proline, β,D-Glu-
cosyl Ester (19)
Starting from compound 18 (35 mg, 0.04 mmol) and following
general procedure B1 19 was obtained as a colourless solid
(11 mg, 68%).
(22) Mikula, H.; Matscheko, D.; Schwarz, M.; Hametner, C.; Fröhlich,
J. Carbohydr. Res. 2013, 370, 19.
(30) Guo, Y.; Zhao, Y.; Zheng, C.; Meng, Y.; Yang, Y. Chem. Pharm.
Bull. 2010, 58, 1627.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2018, 29, A–D